Product Description
Overall, the global capsule endoscopy market was valued at approximately $405 million in 2021. This is expected to increase over the forecast period at a CAGR of 4.1% to reach nearly $538 million.
The full report suite on the global market for capsule endoscopy includes camera capsule endoscopy devices.
MARKET REPORT DATA TYPES INCLUDED
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- Procedure Numbers
- COVID-19 Impact Analysis
- Market Drivers & Limiters
- Market Forecasts Until 2028, and Historical Data to 2018
- Recent Mergers & Acquisitions
- Company Profiles and Product Portfolios
- Leading Competitors
PROCEDURE NUMBERS
In recent years, capsule endoscopy procedures have gained significant credibility, although the diagnostic and elective nature of this procedure has limited growth, as some individuals opt to avoid the procedure. Nonetheless, the use of capsule endoscopy to diagnose conditions in the colon is expected to drive growth in procedure numbers over the forecast period.
GLOBAL CAPSULE ENDOSCOPY DEVICE MARKET TRENDS
The camera capsule market is expected to grow in both the short and long-term; the current drivers include favorable reimbursement, coupled with expanding indications into the esophageal and colonic markets. In the long-term, the camera capsule market is expected to benefit from the ongoing research that addresses the major limitations of the device: its non-therapeutic nature and lack of control of the capsule passage.
GLOBAL CAPSULE ENDOSCOPY DEVICE MARKET SHARE INSIGHTS
Overall, within the global capsule endoscopy device market there are three dominant competitors: Medtronic, Jianshan Science, and Ankon Medical.In 2021, the leading competitor in the capsule endoscopy market was Medtronic, with the large majority of the total market share. Medtronic held the leading market share in North America and Western Europe, and the second-leading share in the rest of the world, behind Jianshan.
MARKET SEGMENTATION SUMMARY
-
Camera Capsule Endoscopy Market
Research Scope Summary
Report Attribute | Details |
---|---|
Regions | North America (Canada, United States) Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela) Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.) Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam) Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
Base Year | 2021 |
Forecast Period | 2022-2028 |
Historical Data | 2018-2021 |
Quantitative Data | Market Size, Market Share, Market Growth Rates, Units Sold, Average Selling Prices |
Qualitative Data | COVID-19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios |
Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data.
Read more about iData’s 9-Step Research Methodology |
WHY CHOOSE iDATA?
- Experts Only – iData has been around for over 17 years and is the trusted source of intelligence, and data-driven insights for key industry players. We are made up of specialists with a sole focus on medical devices, dental devices and pharmaceuticals. Our research and consulting field of endeavour never strays from the medical device industry and, because of this, we are the number one choice for leading companies in this field.
- Global Coverage – iData’s unique methodology, and its expansion to over 70 countries world-wide, has made it one of the most viable sources of intelligence for global companies along with those who plan to expand their portfolio beyond the confines of their own country. Providing procedural data at the country level is another testimony to the trusted global coverage we provide.
- Attention to Detail – It’s our attention to small details, scheduling of timelines, and keen project management that makes us stand out from the rest. We are creative, and our reports include metrics such as procedure numbers, ASPs, and SKU-level insights that are not found elsewhere.
- Pricing – When comparing like-with-like, iData’s prices are not only extremely competitive but also the most cost-effective. We strive for success and want the same for our clients. With the level of detail incorporated into each report alongside the extensive segmentation provided, no other report compares at our price point.